AstraZeneca partners on AI drug discovery collaboration

02-05-2019

AstraZeneca partners on AI drug discovery collaboration

360b / Shutterstock.com

AstraZeneca has begun collaborating with UK-headquartered artificial intelligence (AI) company BenevolentAI to use AI and machine learning for the discovery and development of new treatments.


AstraZeneca, Benevolent AI, drug discovery, machine learning, artificial intelligence, drug development

LSIPR